Lineage Cell Therapeutics Inc (AMEX:LCTX)
$ 0.6126 0.0052 (0.86%) Market Cap: 133.88 Mil Enterprise Value: 103.92 Mil PE Ratio: 0 PB Ratio: 1.74 GF Score: 61/100

Q2 2024 Lineage Cell Therapeutics Inc Earnings Call Transcript

Aug 08, 2024 / 08:30PM GMT
Release Date Price: $0.8806 (+1.80%)
Operator

Welcome to the Lineage Cell Therapeutics second quarter 2024 conference call. At this time, all participants are in a listen only mode. An audio webcast of this call is available on the Investors section of Lineage website at www.lineagecell.com.

This call is subject to copyright. It is the property of Lineage and recordings, reproduction or transmission of this call without the express written consent of Lineage, are strictly prohibited. As a reminder, today's call is being recorded. I would now like to introduce your host for today's call Ms. Ioana Hone, Head of Investor Relations at Lineage. Ms. Hone, please go ahead.

Ioana Hone
Lineage Cell Therapeutics Inc - Head of Investor Relations

Thank you. Good afternoon and thank you for joining us. a press release reporting our second quarter 2024 financial results was issued earlier today August 8, 2024, and can be found on the Investors section of our website.

Please note that today's remarks and responses to your questions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot